Stay updated with breaking news from Mor Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Over the next three and a half years, the AI4Lungs project will develop AI tools and computational models to optimise patient categorisation, improving diagnoses and treatments.
Altimmune (NASDAQ:ALT – Get Free Report) and Purple Biotech (NASDAQ:PPBT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Profitability This table compares Altimmune and Purple Biotech’s […]
Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple
Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, Feb. ...
Lydus Medical, a Ra’Anana, Israel-based developer of a novel product line for automating the creation of small blood vessel anastomoses, raised $2.7m in Pre-A funding. The round was led by an undisclosed US based strategic player with the participation from Sanara Ventures, and existing backers Mor Research, Technion and Leon Recanati’s private equity investment company, Glenrock. The company intends to use the funds to accelerate FDA clearance while scaling product development and prepare for market entry. Led by Jessica Weiss, CEO, Lydus developed the Vesseal, a surgical device th...